Clinical Trials Browser

Withdrawn × Lung Neoplasms × Clear all

NCT03804255 2026-05-06

Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Colorectal Neoplasms

NCT06572722 2026-04-27

Perioperative Immunotherapy for NSCLC (ECTOP-1030)

Phase 2 Withdrawn

Lung Neoplasms

NCT06836414 2026-04-13

Lung Cancer Screening CT for Firefighters

Phase NA Withdrawn

Lung Diseases, Lung Neoplasms, Smoke Inhalation Injury, Lung Diseases, Interstitial, Respiratory Aspiration

NCT06713798 2026-03-23

INDIGO

Phase 2 Withdrawn

Lung Neoplasms

NCT06746324 2025-09-15

AI-Lung

Lung Neoplasms

NCT06555263 2025-08-22

Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02264236 2025-07-20

Vaccination of Advanced-Stage Lung Cancer Patients

Phase 1/2 Withdrawn

Lung Neoplasms

NCT05879484 2025-07-10

Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS

Phase 1/2 Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lung Neoplasms

NCT06494046 2025-06-04

Defining Musical Toxicity and Its Effect on Patient Well-being

BreastCNSGastrointestinalThoracic

Brain Neoplasms, Breast Neoplasms, Esophageal Neoplasms, Lung Neoplasms

NCT05840770 2025-05-26

Cemiplimab for the Treatment of Untreated Brain Metastases From PD-L1 >= 50% Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05358691 2025-04-16

A Trial of AN0025 With Chemoradiation Therapy in Stage III NSCLC Participants

Phase 1 Withdrawn

Lung Neoplasms

NCT06895941 2025-04-08

Predictive Value of PET/CT for Efficacy of Neoadjuvant Immunotherapy in Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT03167281 2025-02-21

ELEVATE

Phase 4 Withdrawn

Lung Neoplasms, Pleural Diseases, Pleural Effusion, Pneumothorax, Pulmonary Embolism

NCT05426213 2025-02-03

A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung Lesions

Phase NA Withdrawn

Lung Neoplasms

NCT06135545 2025-01-09

Bupivacaine Liposome Serrate Anterior Plane Block vs Traditional Thoracic Paravertebral Block

Phase NA Withdrawn

Lung Neoplasms, Pain, Postoperative

NCT02347839 2024-12-10

NEGOTIATE

Phase 2 Withdrawn

Lung Neoplasms

NCT02428764 2024-12-10

Neoadjuvant Nimotuzumab Plus Gemcitabine and Carboplatin in Unresectable Stage III Squamous Cell Lung Carcinoma

Phase 2 Withdrawn

Lung Neoplasms

NCT03164694 2024-12-10

APPEAL

Phase 2 Withdrawn

Lung Neoplasms

NCT06227897 2024-12-10

AERESA

Phase 2 Withdrawn

Lung Neoplasms

NCT06722885 2024-12-09

SBRT_LOV

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms

NCT02699229 2024-12-04

Non-linear Multimodal Microendoscopy for Lung Cancer Pathology

Lung Neoplasms

NCT03622528 2024-11-27

Quantitative Lung Cancer Screening

Lung Diseases, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT04318249 2024-11-25

LC_ART

Phase NA Withdrawn

Sleep Initiation and Maintenance Disorders, Lung Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT04987281 2024-10-23

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06427369 2024-09-27

An Investigational Scan (124I-hJAA-F11 PET/CT) for Diagnosing Lung Cancer

Phase 1 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Small Cell Lung Carcinoma

NCT06024941 2024-09-19

Re-Induce 2

Phase 2 Withdrawn

Lung Neoplasms

NCT04944173 2024-09-03

SCION

Phase 2 Withdrawn

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT04931420 2024-07-31

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

Phase 2 Withdrawn

GastrointestinalThoracic

Gastrointestinal Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

NCT06017271 2024-07-22

Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer

Lung Neoplasms, Pulmonary Embolism

NCT05039931 2024-07-18

A Study of GNC-035, a Tetra-specific Antibody, in Participants With Locally Advanced or Metastatic Solid Tumors

Phase 1 Withdrawn

Breast Neoplasms, Lung Neoplasms

NCT05364645 2024-07-09

Testing the Use of Targeted Treatment for RET Positive Advanced Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05471401 2024-06-13

GI Organ Tracking Via Balloon Applicators

Phase NA Withdrawn

GastrointestinalGenitourinaryHead & NeckThoracic

Colonic Neoplasms, Esophageal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04584775 2024-06-12

Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care

Phase NA Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Colonic Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Signs and Symptoms, Cholangiocarcinoma

NCT05411107 2024-05-17

Oral Iloprost for the Prevention of Lung Cancer In Former Smokers

Phase 2 Withdrawn

Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

NCT06284226 2024-04-16

CCT-ANK-11

Phase EARLY_PHASE1 Withdrawn

GastrointestinalGynecologicThoracic

Esophageal Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Cholangiocarcinoma

NCT05412875 2024-04-12

Pilot Trial of E Cigarettes in Pts Diagnosed With Cancer of the Head, Neck, and Lung

Phase NA Withdrawn

Head & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05703555 2024-02-28

INTRUSION

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms

NCT05848843 2024-01-23

A Phase I Study of Adagrasib and Durvalumab for Treatment of Advanced Non-small Cell Lung Cancers and Gastro-intestinal Cancers Harboring KRAS G12C Mutations

Phase 1 Withdrawn

Lung Neoplasms

NCT05948462 2023-12-13

NSCLC

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT00548730 2023-12-11

NWA

Lung Neoplasms

NCT04648189 2023-10-19

Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC

Phase 2 Withdrawn

Lung Neoplasms, Neoplastic Cells, Circulating

NCT05161533 2023-10-18

Hypofractionated Radiation Therapy After Durvalumab and Chemotherapy for the Treatment of Stage IV Extensive Stage Small Cell Lung Cancer, CASPIAN-RT Trial

Phase 2 Withdrawn

Lung Neoplasms

NCT04917224 2023-09-26

LUNG STAAR

Phase NA Withdrawn

Lung Neoplasms

NCT04989283 2023-09-26

Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05045404 2023-09-13

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05230888 2023-09-01

Comprehensive Geriatric Assessment in Elderly Non-Small Cell Lung Cancer Patients

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05935774 2023-08-25

OT-101 in Combination With Atezolizumab for the Treatment of Metastatic or Recurrent Non-Small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00863824 2023-08-14

NNAL

Lung Neoplasms

NCT05653531 2023-07-20

HEPATICI

Phase NA Withdrawn

Lung Neoplasms